Clario mourns the passing of Joel Morganroth, M.D.
He was a visionary founder who shaped cardiac safety and clinical research, leaving a lasting legacy.
See the latest news and media coverage for Clario. We track all announcements, press releases, and industry mentions in real time, all in one place.
Clinical trial endpoint technology and services provider
clario.comLast updated
In short: Clario was acquired by Thermo Fisher Scientific for approximately $8.9 billion while expanding its AI-driven clinical trial capabilities.
He was a visionary founder who shaped cardiac safety and clinical research, leaving a lasting legacy.
Research in Biological Psychiatry reveals excluding high placebo responders via speech latency boosts drug-placebo separation 2-3 times in brilaroxazine Phase III trial. Clario’s Chief Research Officer Mark Opler co-investigated.
The certification, audited by Schellman, underscores Clario's leadership in responsible AI for clinical trials, complementing ISO 27701 and 27001 standards.
The guidance highlights ArtiQ.Spiro's potential to enable high-quality testing in primary care, expand access, and reduce waiting times.
Clario Group, a global strategic integrated communications and advisory firm, today announced the acquisition of Ted Miller Group (TMG), a Miami-founded boutique public relations agency...
Thermo Fisher Scientific Inc. (TMO) is up 4.1% today. Here is some analysis on what might have caused this price movement.Analysis: There does not appear...
Nordic, Astorg, Cinven and Novo Holdings closed on the $8.9bn all-cash sale of Clario Holdings to Thermo Fisher Scientific in March.
XROI™ anchors a broader suite of AI-powered solutions designed to elevate leadership performance and organizational impactNEW YORK, April 27, 2026 /PRNewswire/ -- Clario Group today...
Track Clario and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.